Mirae Asset Global ETFs Holdings
KURA icon

Mirae Asset Global ETFs Holdings’s Kura Oncology KURA Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$540K Buy
49,243
+1,908
+4% +$18K ﹤0.01% 1965
2026
Q1 		$381K Sell
47,335
-1,031
-2% -$8.86K ﹤0.01% 2024
2025
Q4 		$501K Buy
48,366
+5,436
+13% +$57K ﹤0.01% 1895
2025
Q3 		$381K Sell
42,930
-5,120
-11% -$36.5K ﹤0.01% 2001
2025
Q2 		$277K Sell
48,050
-1,958
-4% -$12K ﹤0.01% 2108
2025
Q1 		$333K Buy
50,008
+2,977
+6% +$23.2K ﹤0.01% 2072
2024
Q4 		$408K Buy
47,031
+3,617
+8% +$52K ﹤0.01% 2023
2024
Q3 		$848K Buy
43,414
+2,930
+7% +$59.4K ﹤0.01% 1633
2024
Q2 		$833K Buy
+40,484
New +$832K ﹤0.01% 1559

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's KURA Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Kura Oncology (KURA) stake by 4% in Q2 2026, buying an estimated $18K and bringing the position to 49,243 shares worth $540K. The position accounts for ﹤0.01% of the portfolio, ranked #1965.

Mirae Asset Global ETFs Holdings first reported a position in KURA in Q2 2024 and has held it in 9 quarters since. The position peaked at $848K in Q3 2024. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 49,243 shares of Kura Oncology worth $540K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 1,908 Kura Oncology shares in Q2 2026, an estimated $18K.
  • Kura Oncology made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1965 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Kura Oncology in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Kura Oncology position peaked at $848K in Q3 2024.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.